» Articles » PMID: 20008873

What Drives the Peripheral Lung-remodeling Process in Chronic Obstructive Pulmonary Disease?

Overview
Specialty Pulmonary Medicine
Date 2009 Dec 17
PMID 20008873
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The smaller airways (<2 mm in diameter) offer little resistance in normal lungs but become the major site of obstruction in chronic obstructive pulmonary disease (COPD). We examined bronchiolar remodeling in COPD by combining quantitative histology, micro-computed tomography (CT), and gene expression studies. Volumes of bronchiolar tissue, total collagen, collagen-1, and collagen-3 were measured in lung tissue from 52 patients with different levels of COPD severity. Micro-CT was used to measure the number and lumen area of terminal bronchioles in four lungs removed before lung transplantation and in four donor lungs that served as controls. Laser capture microdissection provided 136 paired samples of bronchiolar and surrounding lung tissue from 63 patients and the gene expression of a cluster of tissue repair genes was compared. This study shows that total bronchiolar tissue decreased with progression of COPD and was associated with a reduction in total collagen and relative increase in collagen-3 over collagen-1. The micro-CT studies showed a 10-fold reduction in terminal bronchiolar number and a 100-fold reduction in lumen area. Interestingly, most genes associated with tissue accumulation during repair decreased their expression in both airways and in the surrounding lung as FEV(1) declined, but eight genes previously associated with COPD increased expression in the surrounding lung tissue. Our study shows that small airway remodeling is associated with narrowing and obliteration of the terminal bronchioles that begins before emphysematous destruction in COPD and in relation to differential expression of tissue repair genes in the airways and surrounding lung.

Citing Articles

Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease.

Liu G, Hsu A, Geirnaert S, Cong C, Nair P, Shen S Mol Ther. 2025; 33(3):917-932.

PMID: 39838644 PMC: 11897773. DOI: 10.1016/j.ymthe.2025.01.032.


Collagen deposition in lung parenchyma driven by depletion of interstitial Lyve-1 macrophages prevents cigarette smoke-induced emphysema and loss of airway function.

Dagnachew Y, Lim H, Wupeng L, Lim S, Lim S, Thiam C Front Immunol. 2025; 15():1493395.

PMID: 39830508 PMC: 11738928. DOI: 10.3389/fimmu.2024.1493395.


A 3D Epithelial-Mesenchymal Co-Culture Model of the Airway Wall Using Native Lung Extracellular Matrix.

de Hilster R, Reinders-Luinge M, Schuil A, Borghuis T, Harmsen M, Burgess J Bioengineering (Basel). 2024; 11(9).

PMID: 39329688 PMC: 11428669. DOI: 10.3390/bioengineering11090946.


Assessment of Imatinib Anti-Remodeling Activity on a Human Precision Cut Lung Slices Model.

Bozzini S, Bozza E, Bagnera C, Morbini P, Lettieri S, Della Zoppa M Int J Mol Sci. 2024; 25(15).

PMID: 39125756 PMC: 11311718. DOI: 10.3390/ijms25158186.


Investigation of nutrition status and analysis of 180-day readmission factors in elderly hospitalized patients with COPD.

Liu H, Song J, Wang Z, Wu S, Qiu S, Chen B Aging Clin Exp Res. 2024; 36(1):155.

PMID: 39085739 PMC: 11291564. DOI: 10.1007/s40520-024-02820-9.


References
1.
Churg A, Tai H, Coulthard T, Wang R, Wright J . Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med. 2006; 174(12):1327-34. DOI: 10.1164/rccm.200605-585OC. View

2.
Ning W, Li C, Kaminski N, Feghali-Bostwick C, Alber S, Di Y . Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A. 2004; 101(41):14895-900. PMC: 522001. DOI: 10.1073/pnas.0401168101. View

3.
Gosselink J, Hayashi S, Chau E, Cooper J, Elliott W, Hogg J . Evaluation of small sample cDNA amplification for microdissected airway expression profiling in COPD. COPD. 2007; 4(2):91-105. DOI: 10.1080/15412550701246427. View

4.
Murphy-Ullrich J, Poczatek M . Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 2000; 11(1-2):59-69. DOI: 10.1016/s1359-6101(99)00029-5. View

5.
Rabe K, Hurd S, Anzueto A, Barnes P, Buist S, Calverley P . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6):532-55. DOI: 10.1164/rccm.200703-456SO. View